Simply Drug
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Brand Drugs 1.2.3 Generic Drug 1.3 Market by Application 1.3.1 Global Medicine Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Medicine Market Perspective (2017-2028) 2.2 Medicine Growth Trends by Region 2.2.1 Medicine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Medicine Historic Market Size by Region (2017-2022) 2.2.3 Medicine Forecasted Market Size by Region (2023-2028) 2.3 Medicine Market Dynamics 2.3.1 Medicine Industry Trends 2.3.2 Medicine Market Drivers 2.3.3 Medicine Market Challenges 2.3.4 Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Medicine Players by Revenue 3.1.1 Global Top Medicine Players by Revenue (2017-2022) 3.1.2 Global Medicine Revenue Market Share by Players (2017-2022) 3.2 Global Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Medicine Revenue 3.4 Global Medicine Market Concentration Ratio 3.4.1 Global Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Medicine Revenue in 2021 3.5 Medicine Key Players Head office and Area Served 3.6 Key Players Medicine Product Solution and Service 3.7 Date of Enter into Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Medicine Breakdown Data by Type 4.1 Global Medicine Historic Market Size by Type (2017-2022) 4.2 Global Medicine Forecasted Market Size by Type (2023-2028) 5 Medicine Breakdown Data by Application 5.1 Global Medicine Historic Market Size by Application (2017-2022) 5.2 Global Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Medicine Market Size (2017-2028) 6.2 North America Medicine Market Size by Country (2017-2022) 6.3 North America Medicine Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Medicine Market Size (2017-2028) 7.2 Europe Medicine Market Size by Country (2017-2022) 7.3 Europe Medicine Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Medicine Market Size (2017-2028) 8.2 Asia-Pacific Medicine Market Size by Country (2017-2022) 8.3 Asia-Pacific Medicine Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Medicine Market Size (2017-2028) 9.2 Latin America Medicine Market Size by Country (2017-2022) 9.3 Latin America Medicine Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Medicine Market Size (2017-2028) 10.2 Middle East & Africa Medicine Market Size by Country (2017-2022) 10.3 Middle East & Africa Medicine Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Medicine Introduction 11.1.4 Pfizer Revenue in Medicine Business (2017-2022) 11.1.5 Pfizer Recent Development 11.2 Roche 11.2.1 Roche Company Detail 11.2.2 Roche Business Overview 11.2.3 Roche Medicine Introduction 11.2.4 Roche Revenue in Medicine Business (2017-2022) 11.2.5 Roche Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Detail 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Medicine Introduction 11.3.4 Sanofi Revenue in Medicine Business (2017-2022) 11.3.5 Sanofi Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Detail 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Medicine Introduction 11.4.4 Johnson & Johnson Revenue in Medicine Business (2017-2022) 11.4.5 Johnson & Johnson Recent Development 11.5 Merck & Co. (MSD) 11.5.1 Merck & Co. (MSD) Company Detail 11.5.2 Merck & Co. (MSD) Business Overview 11.5.3 Merck & Co. (MSD) Medicine Introduction 11.5.4 Merck & Co. (MSD) Revenue in Medicine Business (2017-2022) 11.5.5 Merck & Co. (MSD) Recent Development 11.6 Novartis 11.6.1 Novartis Company Detail 11.6.2 Novartis Business Overview 11.6.3 Novartis Medicine Introduction 11.6.4 Novartis Revenue in Medicine Business (2017-2022) 11.6.5 Novartis Recent Development 11.7 AbbVie 11.7.1 AbbVie Company Detail 11.7.2 AbbVie Business Overview 11.7.3 AbbVie Medicine Introduction 11.7.4 AbbVie Revenue in Medicine Business (2017-2022) 11.7.5 AbbVie Recent Development 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Detail 11.8.2 Gilead Sciences Business Overview 11.8.3 Gilead Sciences Medicine Introduction 11.8.4 Gilead Sciences Revenue in Medicine Business (2017-2022) 11.8.5 Gilead Sciences Recent Development 11.9 GlaxoSmithKline (GSK) 11.9.1 GlaxoSmithKline (GSK) Company Detail 11.9.2 GlaxoSmithKline (GSK) Business Overview 11.9.3 GlaxoSmithKline (GSK) Medicine Introduction 11.9.4 GlaxoSmithKline (GSK) Revenue in Medicine Business (2017-2022) 11.9.5 GlaxoSmithKline (GSK) Recent Development 11.10 Amgen 11.10.1 Amgen Company Detail 11.10.2 Amgen Business Overview 11.10.3 Amgen Medicine Introduction 11.10.4 Amgen Revenue in Medicine Business (2017-2022) 11.10.5 Amgen Recent Development 11.11 AstraZeneca 11.11.1 AstraZeneca Company Detail 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Medicine Introduction 11.11.4 AstraZeneca Revenue in Medicine Business (2017-2022) 11.11.5 AstraZeneca Recent Development 11.12 Bristol-Myers Squibb 11.12.1 Bristol-Myers Squibb Company Detail 11.12.2 Bristol-Myers Squibb Business Overview 11.12.3 Bristol-Myers Squibb Medicine Introduction 11.12.4 Bristol-Myers Squibb Revenue in Medicine Business (2017-2022) 11.12.5 Bristol-Myers Squibb Recent Development 11.13 Eli Lilly 11.13.1 Eli Lilly Company Detail 11.13.2 Eli Lilly Business Overview 11.13.3 Eli Lilly Medicine Introduction 11.13.4 Eli Lilly Revenue in Medicine Business (2017-2022) 11.13.5 Eli Lilly Recent Development 11.14 Teva 11.14.1 Teva Company Detail 11.14.2 Teva Business Overview 11.14.3 Teva Medicine Introduction 11.14.4 Teva Revenue in Medicine Business (2017-2022) 11.14.5 Teva Recent Development 11.15 Bayer 11.15.1 Bayer Company Detail 11.15.2 Bayer Business Overview 11.15.3 Bayer Medicine Introduction 11.15.4 Bayer Revenue in Medicine Business (2017-2022) 11.15.5 Bayer Recent Development 11.16 Novo Nordisk 11.16.1 Novo Nordisk Company Detail 11.16.2 Novo Nordisk Business Overview 11.16.3 Novo Nordisk Medicine Introduction 11.16.4 Novo Nordisk Revenue in Medicine Business (2017-2022) 11.16.5 Novo Nordisk Recent Development 11.17 Allergan 11.17.1 Allergan Company Detail 11.17.2 Allergan Business Overview 11.17.3 Allergan Medicine Introduction 11.17.4 Allergan Revenue in Medicine Business (2017-2022) 11.17.5 Allergan Recent Development 11.18 Takeda 11.18.1 Takeda Company Detail 11.18.2 Takeda Business Overview 11.18.3 Takeda Medicine Introduction 11.18.4 Takeda Revenue in Medicine Business (2017-2022) 11.18.5 Takeda Recent Development 11.19 Boehringer Ingelheim 11.19.1 Boehringer Ingelheim Company Detail 11.19.2 Boehringer Ingelheim Business Overview 11.19.3 Boehringer Ingelheim Medicine Introduction 11.19.4 Boehringer Ingelheim Revenue in Medicine Business (2017-2022) 11.19.5 Boehringer Ingelheim Recent Development 11.20 Mylan 11.20.1 Mylan Company Detail 11.20.2 Mylan Business Overview 11.20.3 Mylan Medicine Introduction 11.20.4 Mylan Revenue in Medicine Business (2017-2022) 11.20.5 Mylan Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Brand Drugs Table 3. Key Players of Generic Drug Table 4. Global Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Medicine Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Medicine Market Share by Region (2017-2022) Table 8. Global Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Medicine Market Share by Region (2023-2028) Table 10. Medicine Market Trends Table 11. Medicine Market Drivers Table 12. Medicine Market Challenges Table 13. Medicine Market Restraints Table 14. Global Medicine Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Medicine Market Share by Players (2017-2022) Table 16. Global Top Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine as of 2021) Table 17. Ranking of Global Top Medicine Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Medicine Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Medicine Product Solution and Service Table 21. Date of Enter into Medicine Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Medicine Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Medicine Revenue Market Share by Type (2017-2022) Table 25. Global Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Medicine Revenue Market Share by Type (2023-2028) Table 27. Global Medicine Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Medicine Revenue Market Share by Application (2017-2022) Table 29. Global Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Medicine Revenue Market Share by Application (2023-2028) Table 31. North America Medicine Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Medicine Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Medicine Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Medicine Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Medicine Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Medicine Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Medicine Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Medicine Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Medicine Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Medicine Market Size by Country (2023-2028) & (US$ Million) Table 41. Pfizer Company Detail Table 42. Pfizer Business Overview Table 43. Pfizer Medicine Product Table 44. Pfizer Revenue in Medicine Business (2017-2022) & (US$ Million) Table 45. Pfizer Recent Development Table 46. Roche Company Detail Table 47. Roche Business Overview Table 48. Roche Medicine Product Table 49. Roche Revenue in Medicine Business (2017-2022) & (US$ Million) Table 50. Roche Recent Development Table 51. Sanofi Company Detail Table 52. Sanofi Business Overview Table 53. Sanofi Medicine Product Table 54. Sanofi Revenue in Medicine Business (2017-2022) & (US$ Million) Table 55. Sanofi Recent Development Table 56. Johnson & Johnson Company Detail Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson Medicine Product Table 59. Johnson & Johnson Revenue in Medicine Business (2017-2022) & (US$ Million) Table 60. Johnson & Johnson Recent Development Table 61. Merck & Co. (MSD) Company Detail Table 62. Merck & Co. (MSD) Business Overview Table 63. Merck & Co. (MSD) Medicine Product Table 64. Merck & Co. (MSD) Revenue in Medicine Business (2017-2022) & (US$ Million) Table 65. Merck & Co. (MSD) Recent Development Table 66. Novartis Company Detail Table 67. Novartis Business Overview Table 68. Novartis Medicine Product Table 69. Novartis Revenue in Medicine Business (2017-2022) & (US$ Million) Table 70. Novartis Recent Development Table 71. AbbVie Company Detail Table 72. AbbVie Business Overview Table 73. AbbVie Medicine Product Table 74. AbbVie Revenue in Medicine Business (2017-2022) & (US$ Million) Table 75. AbbVie Recent Development Table 76. Gilead Sciences Company Detail Table 77. Gilead Sciences Business Overview Table 78. Gilead Sciences Medicine Product Table 79. Gilead Sciences Revenue in Medicine Business (2017-2022) & (US$ Million) Table 80. Gilead Sciences Recent Development Table 81. GlaxoSmithKline (GSK) Company Detail Table 82. GlaxoSmithKline (GSK) Business Overview Table 83. GlaxoSmithKline (GSK) Medicine Product Table 84. GlaxoSmithKline (GSK) Revenue in Medicine Business (2017-2022) & (US$ Million) Table 85. GlaxoSmithKline (GSK) Recent Development Table 86. Amgen Company Detail Table 87. Amgen Business Overview Table 88. Amgen Medicine Product Table 89. Amgen Revenue in Medicine Business (2017-2022) & (US$ Million) Table 90. Amgen Recent Development Table 91. AstraZeneca Company Detail Table 92. AstraZeneca Business Overview Table 93. AstraZeneca MedicineProduct Table 94. AstraZeneca Revenue in Medicine Business (2017-2022) & (US$ Million) Table 95. AstraZeneca Recent Development Table 96. Bristol-Myers Squibb Company Detail Table 97. Bristol-Myers Squibb Business Overview Table 98. Bristol-Myers Squibb MedicineProduct Table 99. Bristol-Myers Squibb Revenue in Medicine Business (2017-2022) & (US$ Million) Table 100. Bristol-Myers Squibb Recent Development Table 101. Eli Lilly Company Detail Table 102. Eli Lilly Business Overview Table 103. Eli Lilly MedicineProduct Table 104. Eli Lilly Revenue in Medicine Business (2017-2022) & (US$ Million) Table 105. Eli Lilly Recent Development Table 106. Teva Company Detail Table 107. Teva Business Overview Table 108. Teva MedicineProduct Table 109. Teva Revenue in Medicine Business (2017-2022) & (US$ Million) Table 110. Teva Recent Development Table 111. Bayer Company Detail Table 112. Bayer Business Overview Table 113. Bayer MedicineProduct Table 114. Bayer Revenue in Medicine Business (2017-2022) & (US$ Million) Table 115. Bayer Recent Development Table 116. Novo Nordisk Company Detail Table 117. Novo Nordisk Business Overview Table 118. Novo Nordisk MedicineProduct Table 119. Novo Nordisk Revenue in Medicine Business (2017-2022) & (US$ Million) Table 120. Novo Nordisk Recent Development Table 121. Allergan Company Detail Table 122. Allergan Business Overview Table 123. Allergan MedicineProduct Table 124. Allergan Revenue in Medicine Business (2017-2022) & (US$ Million) Table 125. Allergan Recent Development Table 126. Takeda Company Detail Table 127. Takeda Business Overview Table 128. Takeda MedicineProduct Table 129. Takeda Revenue in Medicine Business (2017-2022) & (US$ Million) Table 130. Takeda Recent Development Table 131. Boehringer Ingelheim Company Detail Table 132. Boehringer Ingelheim Business Overview Table 133. Boehringer Ingelheim MedicineProduct Table 134. Boehringer Ingelheim Revenue in Medicine Business (2017-2022) & (US$ Million) Table 135. Boehringer Ingelheim Recent Development Table 136. Mylan Company Detail Table 137. Mylan Business Overview Table 138. Mylan MedicineProduct Table 139. Mylan Revenue in Medicine Business (2017-2022) & (US$ Million) Table 140. Mylan Recent Development Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Medicine Market Share by Type: 2021 VS 2028 Figure 2. Brand Drugs Features Figure 3. Generic Drug Features Figure 4. Global Medicine Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Medicine Report Years Considered Figure 9. Global Medicine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Medicine Market Share by Region: 2021 VS 2028 Figure 12. Global Medicine Market Share by Players in 2021 Figure 13. Global Top Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Medicine Revenue in 2021 Figure 15. North America Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Medicine Market Share by Country (2017-2028) Figure 17. United States Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Medicine Market Share by Country (2017-2028) Figure 21. Germany Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Medicine Market Share by Region (2017-2028) Figure 29. China Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Medicine Market Share by Country (2017-2028) Figure 37. Mexico Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Medicine Market Share by Country (2017-2028) Figure 41. Turkey Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Pfizer Revenue Growth Rate in Medicine Business (2017-2022) Figure 44. Roche Revenue Growth Rate in Medicine Business (2017-2022) Figure 45. Sanofi Revenue Growth Rate in Medicine Business (2017-2022) Figure 46. Johnson & Johnson Revenue Growth Rate in Medicine Business (2017-2022) Figure 47. Merck & Co. (MSD) Revenue Growth Rate in Medicine Business (2017-2022) Figure 48. Novartis Revenue Growth Rate in Medicine Business (2017-2022) Figure 49. AbbVie Revenue Growth Rate in Medicine Business (2017-2022) Figure 50. Gilead Sciences Revenue Growth Rate in Medicine Business (2017-2022) Figure 51. GlaxoSmithKline (GSK) Revenue Growth Rate in Medicine Business (2017-2022) Figure 52. Amgen Revenue Growth Rate in Medicine Business (2017-2022) Figure 53. AstraZeneca Revenue Growth Rate in Medicine Business (2017-2022) Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Medicine Business (2017-2022) Figure 55. Eli Lilly Revenue Growth Rate in Medicine Business (2017-2022) Figure 56. Teva Revenue Growth Rate in Medicine Business (2017-2022) Figure 57. Bayer Revenue Growth Rate in Medicine Business (2017-2022) Figure 58. Novo Nordisk Revenue Growth Rate in Medicine Business (2017-2022) Figure 59. Allergan Revenue Growth Rate in Medicine Business (2017-2022) Figure 60. Takeda Revenue Growth Rate in Medicine Business (2017-2022) Figure 61. Boehringer Ingelheim Revenue Growth Rate in Medicine Business (2017-2022) Figure 62. Mylan Revenue Growth Rate in Medicine Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed
Pfizer Roche Sanofi Johnson & Johnson Merck & Co. (MSD) Novartis AbbVie Gilead Sciences GlaxoSmithKline (GSK) Amgen AstraZeneca Bristol-Myers Squibb Eli Lilly Teva Bayer Novo Nordisk Allergan Takeda Boehringer Ingelheim Mylan
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More